tradingkey.logo

Intuitive Surgical Inc

ISRG

519.040USD

+6.860+1.34%
Fechamento 06/16, 16:00ETCotações atrasadas em 15 min
186.02BValor de mercado
80.09P/L TTM

Intuitive Surgical Inc

519.040

+6.860+1.34%
Mais detalhes de Intuitive Surgical Inc Empresa
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Informações da empresa
Código da empresaISRG
Nome da EmpresaIntuitive Surgical Inc
Data de listagemJun 13, 2000
Fundado em1995
CEOMr. David J. Rosa
Número de funcionários15638
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 13
Endereço1020 Kifer Road
CidadeSUNNYVALE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94086
Telefone14085232100
Sitehttps://www.intuitive.com/en-us/about-us/company
Código da empresaISRG
Data de listagemJun 13, 2000
Fundado em1995
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
231.70K
-0.07%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+6.02%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+31.17%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
2.35K
+46.01%
Dr. Amy L. Ladd, M.D.
Dr. Amy L. Ladd, M.D.
Independent Director
Independent Director
1.41K
+110.13%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
979.00
+307.92%
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
852.00
-55.81%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
231.70K
-0.07%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+6.02%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+31.17%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de abr
Moeda: USDAtualizado em: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
Por RegiãoUSD
Nome
Receita
Proporção
U.S.
5.59B
66.92%
Outside of United states
2.76B
33.08%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
Distribuição de ações
Atualizado em: qui, 15 de mai
Atualizado em: qui, 15 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.07%
BlackRock Institutional Trust Company, N.A.
5.28%
State Street Global Advisors (US)
4.29%
T. Rowe Price Associates, Inc.
3.70%
Fidelity Management & Research Company LLC
2.63%
Other
75.03%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.07%
BlackRock Institutional Trust Company, N.A.
5.28%
State Street Global Advisors (US)
4.29%
T. Rowe Price Associates, Inc.
3.70%
Fidelity Management & Research Company LLC
2.63%
Other
75.03%
Tipos de investidores
Investidores
Proporção
Investment Advisor
42.51%
Investment Advisor/Hedge Fund
35.40%
Bank and Trust
2.46%
Research Firm
2.45%
Pension Fund
2.24%
Hedge Fund
2.16%
Sovereign Wealth Fund
1.42%
Individual Investor
0.50%
Family Office
0.16%
Other
10.70%
Participação acionária institucional
Atualizado em: dom, 19 de jan
Atualizado em: dom, 19 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
3498
321.45M
89.68%
-4.09M
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
2023Q2
2932
311.78M
88.97%
-2.17M
2023Q1
2848
309.16M
88.25%
-6.75M
2022Q4
2840
310.11M
87.74%
-7.77M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
32.06M
8.95%
+364.96K
+1.15%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
18.57M
5.18%
+488.70K
+2.70%
Dec 31, 2024
State Street Global Advisors (US)
15.31M
4.27%
+255.30K
+1.70%
Dec 31, 2024
T. Rowe Price Associates, Inc.
13.96M
3.9%
-133.51K
-0.95%
Dec 31, 2024
Fidelity Management & Research Company LLC
10.49M
2.93%
-117.40K
-1.11%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.76M
2.17%
+243.80K
+3.25%
Dec 31, 2024
Capital World Investors
7.43M
2.07%
+11.93K
+0.16%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
7.37M
2.06%
+98.84K
+1.36%
Feb 28, 2025
JP Morgan Asset Management
7.22M
2.01%
+123.15K
+1.74%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
4.60M
1.28%
+186.51K
+4.23%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: qui, 5 de jun
Atualizado em: qui, 5 de jun
Nome
Proporção
Langar Global HealthTech ETF
26.39%
iShares U.S. Medical Devices ETF
16.34%
Global X Robotics & Artificial Intelligence ETF
9.02%
First Trust Nasdaq Lux Digi Health Solutions ETF
7.89%
Invesco AI and Next Gen Software ETF
7.42%
Franklin Intelligent Machines ETF
6.73%
Neuberger Berman Disrupters ETF
6.33%
Strategas Macro Momentum ETF
5.27%
Goldman Sachs Future Health Care Equity ETF
5.14%
iShares Long-Term US Equity Active ETF
4.85%
Ver Mais
Langar Global HealthTech ETF
Proporção26.39%
iShares U.S. Medical Devices ETF
Proporção16.34%
Global X Robotics & Artificial Intelligence ETF
Proporção9.02%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção7.89%
Invesco AI and Next Gen Software ETF
Proporção7.42%
Franklin Intelligent Machines ETF
Proporção6.73%
Neuberger Berman Disrupters ETF
Proporção6.33%
Strategas Macro Momentum ETF
Proporção5.27%
Goldman Sachs Future Health Care Equity ETF
Proporção5.14%
iShares Long-Term US Equity Active ETF
Proporção4.85%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Aug 05, 2021
Split
1>3
Data
Tipo
Proporção
Aug 05, 2021
Split
1>3
KeyAI